Article
Primary nelfinavir (NFV)-associated resistance mutations during a follow-up period of 108 weeks in protease inhibitor naïve patients treated with NFV-containing regimens in an HIV clinic cohort.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Aug 2003
Tsuchiya Kiyoto, Matsuoka-Aizawa Saori, Yasuoka Akira, Kikuchi Yoshimi, Tachikawa Natsuo, Genka Ikumi, Teruya Katsuji, Kimura Satoshi, Oka Shinichi
Abstract excerpt
BACKGROUND: Nelfinavir (NFV) is a widely prescribed HIV-1 specific protease inhibitor (PI). However, there are only a few reports that have described the long-term effects of NFV-containing regimens, especially with regard to the emergence of drug resistance in inner-city clinics. OBJECTIVES: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.